Role of the antioxidant properties in the gastroprotective and gastric healing activity promoted by Brazilian green propolis and the healing efficacy of Artepillin C.


Journal

Inflammopharmacology
ISSN: 1568-5608
Titre abrégé: Inflammopharmacology
Pays: Switzerland
ID NLM: 9112626

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 19 02 2019
accepted: 16 09 2019
pubmed: 21 11 2019
medline: 11 2 2021
entrez: 21 11 2019
Statut: ppublish

Résumé

Green propolis is a resinous substance used in folk medicine given its anti-inflammatory, antibacterial, and anti-ulcer effects. Our research group has already confirmed the gastroprotective activity of hydroalcoholic extract from green propolis (HEGP), as well as of its main isolated compounds. In continuity, this study evaluated the antioxidant mode of action involved in the preventive effect induced by HEGP, and its therapeutic gastric healing potential on installed ulcers. In addition, the healing effect of its main compound Artepillin C was also investigated. Acute and chronic ulcers were induced in rats by given ethanol or acetic acid, respectively. In acute model, the rats were orally pre-treated with vehicle (water plus 1% Tween, 1 mL/kg), HEGP (30-300 mg/kg), or carbenoxolone (200 mg/kg) 1 h prior the ulcer induction. In the chronic ulcer protocol, the rats received vehicle (water plus 1% Tween, 1 mL/kg), HEGP (300 mg/kg), or omeprazole (20 mg/kg) twice a day by 7 days, whereas groups of mice received vehicle (water plus 1% Tween, 1 mL/kg), Artepillin C (18 mg/kg), or ranitidine (20 mg/kg) twice a day by 4 days. Ulcerated tissue was collected for histological, histochemical, immunostaining, oxidative, and inflammatory analyses. The in vitro scavenger activity of HEGP was also verified using the DPPH assay. The oral pre-treatment with HEGP (100 and 300 mg/kg) prevented the gastric epithelial damage promoted by ethanol. Besides, HEGP (100 and 300 mg/kg) reduced SOD activity about 11% and 26%, respectively, and increased the activity of GST around 20% and CAT in 80%. HEGP (300 mg/kg) also reduced the production of reactive oxygen species, as well as lipoperoxidation levels in the ethanol-ulcerated tissue. In the acetic acid-induced chronic ulcer, the daily treatment with HEGP (300 mg/kg) accelerates the healing process by 71%. In this model, HEGP normalized SOD and CAT activity and increased GST activity by 109% when compared to non-ulcerated rats. In both models, the extract administration increased the mucin PAS staining and reduced the myeloperoxidase activity at the ulcer site. Moreover, the treatment with HEGP enhanced the PCNA immunostaining, but did not alter the concentration of collagen in the acetic acid-ulcerated tissue. The extract had a direct DPPH radical-scavenging ability (LogIC

Identifiants

pubmed: 31745698
doi: 10.1007/s10787-019-00649-7
pii: 10.1007/s10787-019-00649-7
doi:

Substances chimiques

Anti-Ulcer Agents 0
Antioxidants 0
Phenylpropionates 0
Plant Extracts 0
Protective Agents 0
artepillin C 72944-19-5
Propolis 9009-62-5
Catalase EC 1.11.1.6
Peroxidase EC 1.11.1.7
Superoxide Dismutase EC 1.15.1.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1009-1025

Subventions

Organisme : FAPESP
ID : 2017/04138-8
Organisme : CAPES
ID : 001

Auteurs

Philipe Costa (P)

Programa de Pós-Graduação em Ciências Farmacêuticas, Núcleo de Investigações Químico-Farmacêuticas (NIQFAR), Universidade do Vale do Itajaí (UNIVALI), Rua Uruguai, 458, Santa Catarina, SC, 88302-901, Brazil.
Departamento de Morfologia, Universidade do Estado de São Paulo (Unesp), Instituto de Biociências, Botucatu, Rua Professor Antônio Celso Wagner Zanin s/n, São Paulo, SP, 18618-689, Brazil.
Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo (USP), Avenida do Café, s/n, Ribeirão Preto, SP, 14040-903, Brazil.

Lincon Bordignon Somensi (LB)

Programa de Pós-Graduação em Ciências Farmacêuticas, Núcleo de Investigações Químico-Farmacêuticas (NIQFAR), Universidade do Vale do Itajaí (UNIVALI), Rua Uruguai, 458, Santa Catarina, SC, 88302-901, Brazil.

Rita de Cássia Melo Vilhena de Andrade Fonseca da Silva (RCMVAF)

Programa de Pós-Graduação em Ciências Farmacêuticas, Núcleo de Investigações Químico-Farmacêuticas (NIQFAR), Universidade do Vale do Itajaí (UNIVALI), Rua Uruguai, 458, Santa Catarina, SC, 88302-901, Brazil.

Luísa Nathalia Bolda Mariano (LNB)

Programa de Pós-Graduação em Ciências Farmacêuticas, Núcleo de Investigações Químico-Farmacêuticas (NIQFAR), Universidade do Vale do Itajaí (UNIVALI), Rua Uruguai, 458, Santa Catarina, SC, 88302-901, Brazil.

Thaise Boeing (T)

Programa de Pós-Graduação em Ciências Farmacêuticas, Núcleo de Investigações Químico-Farmacêuticas (NIQFAR), Universidade do Vale do Itajaí (UNIVALI), Rua Uruguai, 458, Santa Catarina, SC, 88302-901, Brazil.

Bruna Longo (B)

Programa de Pós-Graduação em Ciências Farmacêuticas, Núcleo de Investigações Químico-Farmacêuticas (NIQFAR), Universidade do Vale do Itajaí (UNIVALI), Rua Uruguai, 458, Santa Catarina, SC, 88302-901, Brazil.
Departamento de Morfologia, Universidade do Estado de São Paulo (Unesp), Instituto de Biociências, Botucatu, Rua Professor Antônio Celso Wagner Zanin s/n, São Paulo, SP, 18618-689, Brazil.
Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo (USP), Avenida do Café, s/n, Ribeirão Preto, SP, 14040-903, Brazil.

Ellen Perfoll (E)

Programa de Pós-Graduação em Ciências Farmacêuticas, Núcleo de Investigações Químico-Farmacêuticas (NIQFAR), Universidade do Vale do Itajaí (UNIVALI), Rua Uruguai, 458, Santa Catarina, SC, 88302-901, Brazil.

Priscila de Souza (P)

Programa de Pós-Graduação em Ciências Farmacêuticas, Núcleo de Investigações Químico-Farmacêuticas (NIQFAR), Universidade do Vale do Itajaí (UNIVALI), Rua Uruguai, 458, Santa Catarina, SC, 88302-901, Brazil.

Lucas Fernando Sérgio Gushiken (LFS)

Departamento de Morfologia, Universidade do Estado de São Paulo (Unesp), Instituto de Biociências, Botucatu, Rua Professor Antônio Celso Wagner Zanin s/n, São Paulo, SP, 18618-689, Brazil.

Cláudia Helena Pellizzon (CH)

Departamento de Morfologia, Universidade do Estado de São Paulo (Unesp), Instituto de Biociências, Botucatu, Rua Professor Antônio Celso Wagner Zanin s/n, São Paulo, SP, 18618-689, Brazil.

Débora Munhoz Rodrigues (DM)

Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo (USP), Avenida do Café, s/n, Ribeirão Preto, SP, 14040-903, Brazil.

Jairo Kenupp Bastos (JK)

Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo (USP), Avenida do Café, s/n, Ribeirão Preto, SP, 14040-903, Brazil.

Sérgio Faloni de Andrade (SF)

Programa de Pós-Graduação em Ciências Farmacêuticas, Núcleo de Investigações Químico-Farmacêuticas (NIQFAR), Universidade do Vale do Itajaí (UNIVALI), Rua Uruguai, 458, Santa Catarina, SC, 88302-901, Brazil.

Luísa Mota da Silva (LM)

Programa de Pós-Graduação em Ciências Farmacêuticas, Núcleo de Investigações Químico-Farmacêuticas (NIQFAR), Universidade do Vale do Itajaí (UNIVALI), Rua Uruguai, 458, Santa Catarina, SC, 88302-901, Brazil. luisa@univali.br.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH